Literature DB >> 16644028

Heterologous expression of proteins from Plasmodium falciparum: results from 1000 genes.

Christopher Mehlin1, Erica Boni, Frederick S Buckner, Linnea Engel, Tiffany Feist, Michael H Gelb, Lutfiyah Haji, David Kim, Colleen Liu, Natascha Mueller, Peter J Myler, J T Reddy, Joshua N Sampson, E Subramanian, Wesley C Van Voorhis, Elizabeth Worthey, Frank Zucker, Wim G J Hol.   

Abstract

As part of a structural genomics initiative, 1000 open reading frames from Plasmodium falciparum, the causative agent of the most deadly form of malaria, were tested in an E. coli protein expression system. Three hundred and thirty-seven of these targets were observed to express, although typically the protein was insoluble. Sixty-three of the targets provided soluble protein in yields ranging from 0.9 to 406.6 mg from one liter of rich media. Higher molecular weight, greater protein disorder (segmental analysis, SEG), more basic isoelectric point (pI), and a lack of homology to E. coli proteins were all highly and independently correlated with difficulties in expression. Surprisingly, codon usage and the percentage of adenosines and thymidines (%AT) did not appear to play a significant role. Of those proteins which expressed, high pI and a hypothetical annotation were both strongly and independently correlated with insolubility. The overwhelmingly important role of pI in both expression and solubility appears to be a surprising and fundamental issue in the heterologous expression of P. falciparum proteins in E. coli. Twelve targets which did not express in E. coli from the native gene sequence were codon-optimized through whole gene synthesis, resulting in the (insoluble) expression of three of these proteins. Seventeen targets which were expressed insolubly in E. coli were moved into a baculovirus/Sf-21 system, resulting in the soluble expression of one protein at a high level and six others at a low level. A variety of factors conspire to make the heterologous expression of P. falciparum proteins challenging, and these observations lay the groundwork for a rational approach to prioritizing and, ultimately, eliminating these impediments.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16644028     DOI: 10.1016/j.molbiopara.2006.03.011

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  102 in total

1.  Metamorphic proteins mediate evolutionary transitions of structure.

Authors:  Itamar Yadid; Noam Kirshenbaum; Michal Sharon; Orly Dym; Dan S Tawfik
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-05       Impact factor: 11.205

2.  Structure determination of glycogen synthase kinase-3 from Leishmania major and comparative inhibitor structure-activity relationships with Trypanosoma brucei GSK-3.

Authors:  Kayode K Ojo; Tracy L Arakaki; Alberto J Napuli; Krishna K Inampudi; Katelyn R Keyloun; Li Zhang; Wim G J Hol; Christophe L M J Verlinde; Ethan A Merritt; Wesley C Van Voorhis
Journal:  Mol Biochem Parasitol       Date:  2010-12-30       Impact factor: 1.759

Review 3.  Large screen approaches to identify novel malaria vaccine candidates.

Authors:  D Huw Davies; Patrick Duffy; Jean-Luc Bodmer; Philip L Felgner; Denise L Doolan
Journal:  Vaccine       Date:  2015-10-01       Impact factor: 3.641

4.  Comparison of histidine recognition in human and trypanosomatid histidyl-tRNA synthetases.

Authors:  Cho Yeow Koh; Allan B Wetzel; Will J de van der Schueren; Wim G J Hol
Journal:  Biochimie       Date:  2014-08-20       Impact factor: 4.079

5.  Selective inhibitors of methionyl-tRNA synthetase have potent activity against Trypanosoma brucei Infection in Mice.

Authors:  Sayaka Shibata; J Robert Gillespie; Angela M Kelley; Alberto J Napuli; Zhongsheng Zhang; Kuzma V Kovzun; Ranae M Pefley; Jocelyn Lam; Frank H Zucker; Wesley C Van Voorhis; Ethan A Merritt; Wim G J Hol; Christophe L M J Verlinde; Erkang Fan; Frederick S Buckner
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

6.  Structure of the conserved hypothetical protein MAL13P1.257 from Plasmodium falciparum.

Authors:  Margaret A Holmes; Frederick S Buckner; Wesley C Van Voorhis; Christopher Mehlin; Erica Boni; Thomas N Earnest; George DeTitta; Joseph Luft; Angela Lauricella; Lori Anderson; Oleksandr Kalyuzhniy; Frank Zucker; Lori W Schoenfeld; Wim G J Hol; Ethan A Merritt
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-02-24

7.  A green fluorescent protein screen for identification of well-expressed membrane proteins from a cohort of extremophilic organisms.

Authors:  Justus Hammon; Dinesh V Palanivelu; Joy Chen; Chintan Patel; Daniel L Minor
Journal:  Protein Sci       Date:  2009-01       Impact factor: 6.725

8.  Expression of functional Plasmodium falciparum enzymes using a wheat germ cell-free system.

Authors:  Devaraja G Mudeppa; Pradipsinh K Rathod
Journal:  Eukaryot Cell       Date:  2013-10-11

9.  Prediction of protein crystallization outcome using a hybrid method.

Authors:  Frank H Zucker; Christine Stewart; Jaclyn dela Rosa; Jessica Kim; Li Zhang; Liren Xiao; Jenni Ross; Alberto J Napuli; Natascha Mueller; Lisa J Castaneda; Stephen R Nakazawa Hewitt; Tracy L Arakaki; Eric T Larson; Easwara Subramanian; Christophe L M J Verlinde; Erkang Fan; Frederick S Buckner; Wesley C Van Voorhis; Ethan A Merritt; Wim G J Hol
Journal:  J Struct Biol       Date:  2010-03-27       Impact factor: 2.867

10.  Meta-analysis of immune epitope data for all Plasmodia: overview and applications for malarial immunobiology and vaccine-related issues.

Authors:  K Vaughan; M Blythe; J Greenbaum; Q Zhang; B Peters; D L Doolan; A Sette
Journal:  Parasite Immunol       Date:  2009-02       Impact factor: 2.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.